Stockreport

Lifecore Biomedical Selected by Nirsum Labs to Provide CDMO Services Supporting Clinical Development of Innovative Opioid Use Disorder Treatment [Yahoo! Finance]

Lifecore Biomedical, Inc.  (LFCR) 
PDF Lifecore to Leverage Differentiated Capabilities and Knowledge in Fill and Finish to Support Nirsum's NIH-Funded NRS-033 Development Program CHASKA, Minn., Dec. 19, 2 [Read more]